Captiva Verde Announces Brian Conlan as CEO
Scottsdale, Arizona--(Newsfile Corp. - December 1, 2025) - Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF) ("Captiva Verde" or the "Company") a public company listed on the Canadian Securities Exchange under the trading symbol PWR and further listed on the US OTC Markets under the symbol CPIVF announces that Brian Conlan has been appointed as the Chief Executive Officer of the company. Brian is the President and co-founder of AHP
Agriculture, Cannabis, Cannabis Manufacturer
2025-12-01 9:00 AM EST | Captiva Verde Wellness Corp.
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with acute myocarditis. Results provide clinical evidence that CardiolRx™ reduces inflammation-driven structural damage in the heart, an important cause of heart failure progression. The ARCHER data strengthen
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-12-01 7:27 AM EST | Cardiol Therapeutics Inc.
Simply Solventless Announces Q3 2025 Financial and Operating Results, Commercial Improvements, and 91 New Product Listings Across Canada
Calgary, Alberta--(Newsfile Corp. - November 27, 2025) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or "the Company") is pleased to announce its financial and operating results for the three and nine months ended September 30, 2025, including fiscal year to date ("YTD") revenue of $34.5 million and Adjusted EBITDA of $7.5 million, significant commercial team and process improvements, and the receipt of 91 new product listings across Canada either dir
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2025-11-27 5:34 PM EST | Simply Solventless Concentrates Ltd.
Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of dietary supplements derived from the Amanita Muscaria mushroom, is pleased to announce the launch of Calmer, a new product offering that delivers twice the potency of its flagship product, Calm. The Company has also enhanced the flavour profile of Calm in
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2025-11-27 7:30 AM EST | Psyched Wellness Ltd.
City View Green Holdings Inc. Announces Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - November 25, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that it proposes to undertake an up to $325,000 non-brokered private placement (the "Offering") of units (each, a "Unit") to be sold at a price of $0.08 per Unit. Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant. Each whole warrant will entitle
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2025-11-25 8:28 PM EST | City View Green Holdings Inc.
MustGrow Announces Record Q3-2025 Results
Saskatoon, Saskatchewan--(Newsfi
Agriculture, Biotechnology, Cannabis, Cannabis Breeder
2025-11-25 4:00 PM EST | MustGrow Biologics Corp.
Herbal Dispatch Provides Update on Sold Out Product Launch
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") is pleased to provide a market update on the retail launch of its highly anticipated 2025 Happy Hour Cannabis Advent Calendar, titled "The Twelve Days of Christmas." This limited-edition pre-roll multi-pack box was made available to BC retailers through the Company's Direct Delivery platform and through BC C
Pharmaceuticals, Cannabis, Cannabis Dispensary
2025-11-25 7:00 AM EST | Herbal Dispatch Inc.
Skye Bioscience to Participate in Upcoming Investment Conferences
San Diego, California--(Newsfile Corp. - November 24, 2025) - Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will participate in the following upcoming investment conferences: Citi Global Healthcare Conference (Miami) 1x1 meetings: Dec. 2 Evercore Annual Healthcare Conference (Coral Gables) Fireside Chat: Dec. 3, 12:55 pm
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-11-24 7:00 AM EST | Skye Bioscience, Inc.
CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, issued the following corrected press release, announcing the Company's financial results for the period ended September 30, 2025. In a news release issued earlier today by Vext, the Company identified
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-11-20 4:31 PM EST | VEXT Science, Inc.
Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million
Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations and continued resilient performance in Arizona. YTD operating cash flow of $8.5 million compared to $(0.7) million in Q3 2024 YTD. Strengthened Ohio retail footprint to five consolidated locations. On track to reach the state dispensary license cap of eight in 20261, positioning Vext to capture sustained growth fro
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-11-20 6:30 AM EST | VEXT Science, Inc.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives Second, Larger 5kg Psilocybin Shipment via USA Controlled Substances Import Permit
Toronto, Ontario--(Newsfile Corp. - November 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws is excited to announce that it has, f
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-11-19 7:45 AM EST | Red Light Holland Corp.
Herbal Dispatch Announces Record-Breaking Month of $4.1M in Sales for October 2025
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") is pleased to announce a record-breaking month of sales for October 2025 and an updated forecast for the fourth quarter of 2025, reflecting continued positive momentum. In October 2025, the Company achieved gross sales of approximately $4.1 million, marking the highest monthly sales in its history and
Pharmaceuticals, Cannabis, Cannabis Dispensary
2025-11-17 7:00 AM EST | Herbal Dispatch Inc.
RETRANSMISSION: Akanda Researching Security Requirements for Full Cultivation License
Toronto, Ontario--(Newsfile Corp. - November 14, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") is researching the security requirements and next steps for a full cultivation license through its cannabis operating subsidiary. Recently, the Company extended its option on its British Columbia asset for an additional two years. While the Company currently operates under its hemp cultivation license, Akanda plans to advance toward a full cultivation license for a range of potenti
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-11-14 8:30 AM EST | Akanda Corp
Akanda Researching Security Requirements for Full Cultivation License
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") is researching the security requirements and next steps for a full cultivation license through its cannabis operating subsidiary. Recently, the Company extended its option on its British Columbia asset for an additional two years. While the Company currently operates under its hemp cultivation license, Akanda plans to advance toward a full cultivation license for a range of potenti
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-11-13 4:05 PM EST | Akanda Corp
Steep Hill Announces Amalgamation Agreement with Good Purpose Investments
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to announce that it has entered into an amalgamation agreement (the "Amalgamation Agreement") dated effective November 12, 2025, with Good Purpose Investments Inc. ("Good Purpose") and 1561117 B.C. Ltd. ("Subco"), a wholly owned subsidiary of the Company, pursuant to which the Company will, by way of a three-cornered amalgama
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-11-13 10:19 AM EST | Steep Hill Inc.
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual property protection in the world's largest pharmaceutical market. This allowance fortifies Cardiol's global intellectual property portfolio, adding to granted and pending patent applications in Europe, Japan, Canada, Australia, and
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-11-13 7:45 AM EST | Cardiol Therapeutics Inc.
Quinsam Reports Q3/2025 Results
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing its Q3/2025 results, with net income of $0.1 million ($0.00 per share basic, $0.00 fully diluted) versus net income of $1.2 million ($0.01 per share basic, $0.01 fully diluted) in Q3/2024. Investors can access the Company's full financial statements on sedarplus.ca. "While our performance
Banking / Financial Services, Cannabis, Cannabis Cultivator, Cannabis Ancillary Service Provider
2025-11-13 7:30 AM EST | Quinsam Capital Corporation
Red Light Holland's Wholly Owned Subsidiary Happy Caps Expands Safeway Partnership to 123 Stores Across the U.S. Pacific Northwest, in Time for American Thanksgiving
Toronto, Ontario--(Newsfile Corp. - November 11, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, is pleased to announce a major U.S. retail expansion milestone for its wholly owned subsidiary, 4316747 Nova Scotia Limited o/a Happy Caps Mushroom Farm ("Happy Caps") with Albertso
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-11-11 8:39 AM EST | Red Light Holland Corp.
Vext to Announce Financial Results for Q3 2025 on November 20, 2025
Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the third quarter ended September 30, 2025, before market open on November 20, 2025. The Company will host a con
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-11-11 7:30 AM EST | VEXT Science, Inc.
Digicann Ventures to Resume Trading on the Canadian Securities Exchange
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2025) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, is pleased to announce that its common shares will resume trading on the Canadian Securities Exchange (the "CSE") on November 11, 2025, under the ticker symbol "DCNN.X". Trading of the securities was halted on September 30, 2024, in connection with the ann
Banking / Financial Services, Cannabis
2025-11-10 9:00 PM EST | Digicann Ventures Inc.